Report - AMERICAN THORACIC SOCIETY DOCUMENTS...targeted PAH therapy (strong recommendation, moderate-quality evidence). Targeted PAH therapy currently includes prostacyclin agonist, endothelin

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form